ClinicalTrials.gg
CompletedNCT00134147Updated Apr 17, 2008

A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control

A Phase 3 interventional study of Inhaled Insulin in Diabetes Mellitus, sponsored by Pfizer. Completed at 121 sites in 7 countries. Open to participants aged 35 Years to 80 Years. Per ClinicalTrials.gov, last updated 2008-04-17.

Sponsored by Pfizer · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
1,100
Allocation
Randomized
Ages
35 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 51 studies testing insulin in Diabetes Mellitus — 1 open to participants now, 2 under way, none of them phase 3. Insulin · Diabetes Mellitus.

Enrollment
3rd of 49
1,100 · median 74
Started
2005
with 2 others
Phase 3
11 of 51
none open now
Registered
3rd of 51
by date
Lead sponsor
5 of 51
Pfizer

Among the 51 studies testing insulin in Diabetes Mellitus, this one is the 3rd largest by enrollment of the 49 interventional ones that give a count, is one of 3 that started in 2005, is one of 11 in phase 3, and was the 3rd registered.

Diabetes Mellitus

8,293 studies on the registry are indexed under Diabetes Mellitus; 1,072 are open to participants now.

Browse Diabetes Mellitus studies →

Open to participants now

1 of the 51 studies testing insulin in Diabetes Mellitus is open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

About insulin

No approval found in the FDA or EMA files read. How studies give it is on its page →

Who these studies take

Of the 648 Diabetes Mellitus studies recruiting now, 357 (55%) set no upper age limit and 195 (30%) stop at 75 or younger; 88 take children under 18; 182 take healthy volunteers.

This study: 35 Years to 80 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 51 studies testing insulin in Diabetes Mellitus, or all of them as a file.
02

Study summary

To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents

03

Conditions studied

  • Diabetes Mellitus

Browse trials for

04

Who can participate

Ages eligible
35 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diabetes mellitus Type 2
  • Failing two or more oral anti-diabetic agents

Exclusion criteria

Exclusion Criteria:

  • Asthma,
  • Smoking
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
1,100 participants

Interventions

06

What researchers measure

Primary outcomes

  1. Glycosylated hemoglobin

Secondary outcomes

  1. Percent of patients achieving good control of fasting glucose and lipids

  2. Rate of hypoglycemia

  3. Changes in body weight

  4. Patient satisfaction

  5. Safety based on adverse events reported and laboratory tests

07

Study locations

121 sites
  • Pfizer Investigational Site
    La Jolla, California 92037, United States
  • Pfizer Investigational Site
    San Diego, California 92128, United States
  • Pfizer Investigational Site
    Washington, District of Columbia 20010, United States
  • Pfizer Investigational Site
    Jacksonville, Florida 32208, United States
  • Pfizer Investigational Site
    Jacksonville, Florida 32209, United States
  • Pfizer Investigational Site
    Miami, Florida 33136, United States
  • Pfizer Investigational Site
    Columbus, Georgia 31904, United States
  • Pfizer Investigational Site
    Overland Park, Kansas 66211, United States
  • Pfizer Investigational Site
    New Orleans, Louisiana 70121, United States
  • Pfizer Investigational Site
    Baltimore, Maryland 21230, United States
  • Pfizer Investigational Site
    Charlotte, North Carolina 28207, United States
  • Pfizer Investigational Site
    Charlotte, North Carolina 28212, United States
  • Pfizer Investigational Site
    Raleigh, North Carolina 27609, United States
  • Pfizer Investigational Site
    Medford, Oregon 97504-8491, United States
  • Pfizer Investigational Site
    Hershey, Pennsylvania 17033-0850, United States
  • Pfizer Investigational Site
    Spartanburg, South Carolina 29303, United States
  • Pfizer Investigational Site
    San Antonio, Texas 78229, United States
  • Pfizer Investigational Site
    San Antonio, Texas 78237, United States
  • Pfizer Investigational Site
    Calgary, Alberta T2L 1K8, Canada
  • Pfizer Investigational Site
    Edmonton, Alberta T5J 3N4, Canada
  • Pfizer Investigational Site
    Red Deer, Alberta T4N 6V7, Canada
  • Pfizer Investigational Site
    Winnipeg, Manitoba R3E 3P4, Canada
  • Pfizer Investigational Site
    Corunna, Ontario N0N 1G0, Canada
  • Pfizer Investigational Site
    Oakville, Ontario L6H 3P1, Canada
  • Pfizer Investigational Site
    Smith Falls, Ontario K7A 4W8, Canada
  • Pfizer Investigational Site
    Charlottetown, Prince Edward Island C1A 5Y9, Canada
  • Pfizer Investigational Site
    Laval, Quebec H7T 2P5, Canada
  • Pfizer Investigational Site
    Montreal, Quebec H3A 1A1, Canada
  • Pfizer Investigational Site
    Bethune CEDEX, 62408, France
  • Pfizer Investigational Site
    Bourg En Bresse, 01012, France
  • Pfizer Investigational Site
    Bron, 69500, France
  • Pfizer Investigational Site
    Corbeil Essonnes Cedex, 91106, France
  • Pfizer Investigational Site
    La Rochelle Cedex, 17019, France
  • Pfizer Investigational Site
    Montpellier CEDEX, F-34295, France
  • Pfizer Investigational Site
    Nantes, 44000, France
  • Pfizer Investigational Site
    Roubaix, 59100, France
  • Pfizer Investigational Site
    TOURS cedex 7, 37044, France
  • Pfizer Investigational Site
    Altenburg, 04600, Germany
  • Pfizer Investigational Site
    Aschaffenburg, 63739, Germany
  • Pfizer Investigational Site
    Bad Oeynhausen/ Volmerdingen, 32549, Germany
  • Pfizer Investigational Site
    Bad-Mergentheim, 97980, Germany
  • Pfizer Investigational Site
    Berlin, 10115, Germany
  • Pfizer Investigational Site
    Berlin, 12687, Germany
  • Pfizer Investigational Site
    Berlin, 14057, Germany
  • Pfizer Investigational Site
    Delmenhorst, 27753, Germany
  • Pfizer Investigational Site
    Dresden, 01219, Germany
  • Pfizer Investigational Site
    Ebersdorf, 96237, Germany
  • Pfizer Investigational Site
    Eisenach, 99817, Germany
  • Pfizer Investigational Site
    Falkensee, 14612, Germany
  • Pfizer Investigational Site
    Furth im Wald, 93437, Germany
  • Pfizer Investigational Site
    Hamburg, 21073, Germany
  • Pfizer Investigational Site
    Hamburg, 22391, Germany
  • Pfizer Investigational Site
    Hassloch, 67454, Germany
  • Pfizer Investigational Site
    Kuenzing, 94550, Germany
  • Pfizer Investigational Site
    Leipzig, 04103, Germany
  • Pfizer Investigational Site
    Meissen, 01662, Germany
  • Pfizer Investigational Site
    Mittweida, 09648, Germany
  • Pfizer Investigational Site
    Muenster, 48145, Germany
  • Pfizer Investigational Site
    Muenster, 48153, Germany
  • Pfizer Investigational Site
    Offenbach, 63065, Germany
  • Pfizer Investigational Site
    Offenburg, 77654, Germany
  • Pfizer Investigational Site
    Oschatz, 04758, Germany
  • Pfizer Investigational Site
    Pirna, 01796, Germany
  • Pfizer Investigational Site
    Riedlhuette, 94566, Germany
  • Pfizer Investigational Site
    Riesa, 01587, Germany
  • Pfizer Investigational Site
    Rossach, 96269, Germany
  • Pfizer Investigational Site
    Schwabenheim, 55270, Germany
  • Pfizer Investigational Site
    St.Ingbert, 66386, Germany
  • Pfizer Investigational Site
    Surwold, 26903, Germany
  • Pfizer Investigational Site
    Wangen / Allgaeu, 88239, Germany
  • Pfizer Investigational Site
    Wangen, 88239, Germany
  • Pfizer Investigational Site
    Witten, 58455, Germany
  • Pfizer Investigational Site
    Bari, 70124, Italy
  • Pfizer Investigational Site
    Catania, 95122, Italy
  • Pfizer Investigational Site
    Firenze, 50134, Italy
  • Pfizer Investigational Site
    Genova, 16132, Italy
  • Pfizer Investigational Site
    Milano, 20132, Italy
  • Pfizer Investigational Site
    Napoli, 80131, Italy
  • Pfizer Investigational Site
    Padova, 35128, Italy
  • Pfizer Investigational Site
    Palermo, 90127, Italy
  • Pfizer Investigational Site
    Pescara, 65100, Italy
  • Pfizer Investigational Site
    Pisa, 56124, Italy
  • Pfizer Investigational Site
    Roma, 00133, Italy
  • Pfizer Investigational Site
    Torino, 10126, Italy
  • Pfizer Investigational Site
    Udine, 33100, Italy
  • Pfizer Investigational Site
    Verona, 37126, Italy
  • Pfizer Investigational Site
    Badalona, Barcelona 08916, Spain
  • Pfizer Investigational Site
    Las Palmas, Las Palmas de Gran Canaria 35010, Spain
  • Pfizer Investigational Site
    Baracaldo, Vizcaya 48903, Spain
  • Pfizer Investigational Site
    Bilbao, Vizcaya 48013, Spain
  • Pfizer Investigational Site
    Barcelona, 08003, Spain
  • Pfizer Investigational Site
    Barcelona, 08017, Spain
  • Pfizer Investigational Site
    Barcelona, 08036, Spain
  • Pfizer Investigational Site
    Cadiz, 11009, Spain
  • Pfizer Investigational Site
    Gerona, 17007, Spain
  • Pfizer Investigational Site
    Granada, 18012, Spain
  • Pfizer Investigational Site
    Madrid, 28034, Spain
  • Pfizer Investigational Site
    Madrid, 28040, Spain
  • Pfizer Investigational Site
    Sevilla, 41014, Spain
  • Pfizer Investigational Site
    Valencia, 46017, Spain

Showing the first 100 of 121 sites across 7 countries. Choose a country and city above to see the rest.

08

References and documents

Publications

  • Freemantle N, Strack TR; Real World Trialists. Will availability of inhaled human insulin (Exubera) improve management of type 2 diabetes? The design of the Real World trial. Trials. 2006 Aug 10;7:25. doi: 10.1186/1745-6215-7-25. PubMed 16901335 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2005 and a completion of May 2007. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2005
First posted
Aug 24, 2005
Start
Apr 2005
CompletionActual
May 2007
Last update
Apr 17, 2008
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 17, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00134147
Lead sponsor
Pfizer
Collaborators
Sanofi
First posted
Aug 24, 2005
Start date
Apr 2005
Completion
May 2007
Last update
Apr 17, 2008

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Insulin

Start the discussion